All In MedTech

FDA Clearance Tracker · P890003-S378

MyCareLink Patient Monitor, Device Command Library (DCL) , Device Data Management Application (DDMA) CareLink Express, C

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 19, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 19, 2017

Approved

Time to decision

90 days

Received Jul 21, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P890003-S378
Device name
MyCareLink Patient Monitor, Device Command Library (DCL) , Device Data Management Application (DDMA) CareLink Express, C
Applicant location
Mounds View, MN
Received
Jul 21, 2017
Decided
Oct 19, 2017
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P890003

Device type

Device class
Class III

Every decision under product code NVZ

FDA's approval statement

As written in FDA's record.

Approval for CareLink Support of Percepta/Percepta Quad, Serena/Serena Quad, and Solara/Solara Quad CRT-P MRI SureScan Implantable Pulse Generators with Cardiac Resynchronization Therapy.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.